Susquehanna International Group, LLP Plus Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.48 - $7.5 $22,191 - $346,740	46,232 New	46,232 $21,000
Q2 2022 Aug 15, 2022	SELL	$0.46 - $1.02 $5,033 - $11,160	-10,942 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.87 - $1.32 $19,201 - $29,133	-22,071 Reduced 66.86%	10,942 $11,000
Q4 2021 Feb 14, 2022	BUY	$1.03 - $1.94 $34,003 - $64,045	33,013 New	33,013 $35,000
Q4 2019 Feb 14, 2020	SELL	$1.99 - $3.23 $58,515 - $94,978	-29,405 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.3 - $19.25 $97,036 - $566,046	29,405 New	29,405 $101,000

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $36.6M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.